Cargando…

Utility of the first few100 approach during the 2009 influenza A(H1N1) pandemic in the Netherlands

BACKGROUND: To guide policy and control measures, decent scientific data are needed for a comprehensive assessment of epidemiological, clinical and virological characteristics of the First Few hundred (FF100) cases. We discuss the feasibility of the FF100 approach during the 2009 pandemic and the ad...

Descripción completa

Detalles Bibliográficos
Autores principales: van Gageldonk-Lafeber, Arianne B, van der Sande, Marianne AB, Meijer, Adam, Friesema, Ingrid HM, Donker, Gé A, Reimerink, Johan, Robert-Du Ry van Beest Holle, Mirna, Prins, Jan M, Isken, Leslie, Schellevis, François G, van der Lubben, Mariken IM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511807/
https://www.ncbi.nlm.nih.gov/pubmed/22995284
http://dx.doi.org/10.1186/2047-2994-1-30
_version_ 1782251654026887168
author van Gageldonk-Lafeber, Arianne B
van der Sande, Marianne AB
Meijer, Adam
Friesema, Ingrid HM
Donker, Gé A
Reimerink, Johan
Robert-Du Ry van Beest Holle, Mirna
Prins, Jan M
Isken, Leslie
Schellevis, François G
van der Lubben, Mariken IM
author_facet van Gageldonk-Lafeber, Arianne B
van der Sande, Marianne AB
Meijer, Adam
Friesema, Ingrid HM
Donker, Gé A
Reimerink, Johan
Robert-Du Ry van Beest Holle, Mirna
Prins, Jan M
Isken, Leslie
Schellevis, François G
van der Lubben, Mariken IM
author_sort van Gageldonk-Lafeber, Arianne B
collection PubMed
description BACKGROUND: To guide policy and control measures, decent scientific data are needed for a comprehensive assessment of epidemiological, clinical and virological characteristics of the First Few hundred (FF100) cases. We discuss the feasibility of the FF100 approach during the 2009 pandemic and the added value compared with alternative data sources available. METHODS: The pandemic preparedness plan enabled us to perform a case–control study, assessing patient characteristics and risk factors for experiencing symptomatic influenza A(H1N1)2009 infection and providing insight into transmission. We assessed to what extent timely and novel data were generated compared to other available data sources. RESULTS: In May-December 2009, a total of 68 cases and 48 controls were included in the study. Underlying non-respiratory diseases were significantly more common among cases compared to controls, while a protective effect was found for frequent hand washing. Seroconversion was found for 7/30 controls (23%), and persisting high titers for 4/30 controls (13%). The labour-intensive study design resulted in slow and restricted recruitment. CONCLUSIONS: The findings of our case–control study gave new insights in transmission risks and possible interventions for improved control. Nevertheless, the FF100 approach lacked timeliness and power due to limited recruitment. For future pandemics we suggest pooling data from several countries, to enable collecting sufficient data in a relatively short period.
format Online
Article
Text
id pubmed-3511807
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35118072012-12-02 Utility of the first few100 approach during the 2009 influenza A(H1N1) pandemic in the Netherlands van Gageldonk-Lafeber, Arianne B van der Sande, Marianne AB Meijer, Adam Friesema, Ingrid HM Donker, Gé A Reimerink, Johan Robert-Du Ry van Beest Holle, Mirna Prins, Jan M Isken, Leslie Schellevis, François G van der Lubben, Mariken IM Antimicrob Resist Infect Control Research BACKGROUND: To guide policy and control measures, decent scientific data are needed for a comprehensive assessment of epidemiological, clinical and virological characteristics of the First Few hundred (FF100) cases. We discuss the feasibility of the FF100 approach during the 2009 pandemic and the added value compared with alternative data sources available. METHODS: The pandemic preparedness plan enabled us to perform a case–control study, assessing patient characteristics and risk factors for experiencing symptomatic influenza A(H1N1)2009 infection and providing insight into transmission. We assessed to what extent timely and novel data were generated compared to other available data sources. RESULTS: In May-December 2009, a total of 68 cases and 48 controls were included in the study. Underlying non-respiratory diseases were significantly more common among cases compared to controls, while a protective effect was found for frequent hand washing. Seroconversion was found for 7/30 controls (23%), and persisting high titers for 4/30 controls (13%). The labour-intensive study design resulted in slow and restricted recruitment. CONCLUSIONS: The findings of our case–control study gave new insights in transmission risks and possible interventions for improved control. Nevertheless, the FF100 approach lacked timeliness and power due to limited recruitment. For future pandemics we suggest pooling data from several countries, to enable collecting sufficient data in a relatively short period. BioMed Central 2012-09-21 /pmc/articles/PMC3511807/ /pubmed/22995284 http://dx.doi.org/10.1186/2047-2994-1-30 Text en Copyright ©2012 van Gageldonk-Lafeber et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
van Gageldonk-Lafeber, Arianne B
van der Sande, Marianne AB
Meijer, Adam
Friesema, Ingrid HM
Donker, Gé A
Reimerink, Johan
Robert-Du Ry van Beest Holle, Mirna
Prins, Jan M
Isken, Leslie
Schellevis, François G
van der Lubben, Mariken IM
Utility of the first few100 approach during the 2009 influenza A(H1N1) pandemic in the Netherlands
title Utility of the first few100 approach during the 2009 influenza A(H1N1) pandemic in the Netherlands
title_full Utility of the first few100 approach during the 2009 influenza A(H1N1) pandemic in the Netherlands
title_fullStr Utility of the first few100 approach during the 2009 influenza A(H1N1) pandemic in the Netherlands
title_full_unstemmed Utility of the first few100 approach during the 2009 influenza A(H1N1) pandemic in the Netherlands
title_short Utility of the first few100 approach during the 2009 influenza A(H1N1) pandemic in the Netherlands
title_sort utility of the first few100 approach during the 2009 influenza a(h1n1) pandemic in the netherlands
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511807/
https://www.ncbi.nlm.nih.gov/pubmed/22995284
http://dx.doi.org/10.1186/2047-2994-1-30
work_keys_str_mv AT vangageldonklafeberarianneb utilityofthefirstfew100approachduringthe2009influenzaah1n1pandemicinthenetherlands
AT vandersandemarianneab utilityofthefirstfew100approachduringthe2009influenzaah1n1pandemicinthenetherlands
AT meijeradam utilityofthefirstfew100approachduringthe2009influenzaah1n1pandemicinthenetherlands
AT friesemaingridhm utilityofthefirstfew100approachduringthe2009influenzaah1n1pandemicinthenetherlands
AT donkergea utilityofthefirstfew100approachduringthe2009influenzaah1n1pandemicinthenetherlands
AT reimerinkjohan utilityofthefirstfew100approachduringthe2009influenzaah1n1pandemicinthenetherlands
AT robertduryvanbeesthollemirna utilityofthefirstfew100approachduringthe2009influenzaah1n1pandemicinthenetherlands
AT prinsjanm utilityofthefirstfew100approachduringthe2009influenzaah1n1pandemicinthenetherlands
AT iskenleslie utilityofthefirstfew100approachduringthe2009influenzaah1n1pandemicinthenetherlands
AT schellevisfrancoisg utilityofthefirstfew100approachduringthe2009influenzaah1n1pandemicinthenetherlands
AT vanderlubbenmarikenim utilityofthefirstfew100approachduringthe2009influenzaah1n1pandemicinthenetherlands